Icariin Acts as a Potential Agent for Preventing Cardiac Ischemia/Reperfusion Injury

Cell Biochemistry and Biophysics

Volumn 72, Issue 2, 2015, Pages 589-597

  Zhai, Minghe ^a   He, Liang ^a   Ju, Xingai ^a   Shao, Ling ^a   Li, Guang ^a   Zhang, Yunli ^a   Liu, Yanjiao ^a   Zhao, Hongmei ^a  

^a People s Hospital of Liaoning Province   (China)

Author keywords

I R; Icariin; Myocardial; PI3K Akt eNOS

Indexed keywords

EPIMEDIUM KOREANUM; RATTUS;

CARDIOTONIC AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLAVONOID; HERBACEOUS AGENT; ICARIIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR;

ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CARDIAC MUSCLE CELL; DRUG EFFECTS; MALE; METABOLISM; MYOCARDIAL REPERFUSION INJURY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; CARDIOTONIC AGENTS; DRUGS, CHINESE HERBAL; FLAVONOIDS; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84930869096     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-014-0506-3     Document Type: Article

References (31)

1. Cannon, B. (2013). Cardiovascular disease: Biochemistry to behaviour. Nature,2013(493), S2–S3.
2. Murray, C. J., & Lopez, A. D. (1997). Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet,1997(349), 1498–1504.
3. Piper, H. M., Garcia-Dorado, D., & Ovize, M. (1998). A fresh look at reperfusion injury. Cardiovascular Research,1998(38), 291–300.
4. Rohilla, A., Khan, M. U., & Khanam, R. (2012). Cardioprotective potential of simvastatin in the hyperhomocysteinemic rat heart. Journal of Advanced Pharmaceutical Technology & Research,2012(3), 193–198.
5. Kawamoto, A., Gwon, H. C., Iwaguro, H., Yamaguchi, J. I., Uchida, S., Masuda, H., et al. (2001). Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation,2001(103), 634–637.
6. Tsang, A., Hausenloy, D. J., Mocanu, M. M., & Yellon, D. M. (2004). Postconditioning: A form of “modified reperfusion” protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circulation Research,2004(95), 230–232.
7. Ehrenreich, H., Timner, W., & Siren, A. L. (2004). A novel role for an established player: Anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemia. Transfusion and Apheresis Science,2004(31), 39–44.
8. Kiss, L., Deitch, E. A., & Szabo, C. (2008). Hydrogen sulfide decreases adenosine triphosphate levels in aortic rings and leads to vasorelaxation via metabolic inhibition. Life Sciences,2008(83), 589–594.
9. Li, S., Dong, P., Wang, J., Zhang, J., Gu, J., Wu, X., et al. (2010). Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathway. Cancer Letters,2010(298), 222–230.
10. Liu, Z. Q. (2006). Icariin: A special antioxidant to protect linoleic acid against free-radical-induced peroxidation in micelles. Journal of Physical Chemistry A,2006(110), 6372–6378.
11. Liu, Z. Q., Luo, X. Y., Sun, Y. X., Wu, W., Liu, C. M., Liu, Z. Q., & Liu, S. Y. (2004). The antioxidative effect of icariin in human erythrocytes against free-radical-induced haemolysis. Journal of Pharmacy and Pharmacology,2004(56), 1557–1562.
12. Pan, Y., Kong, L., Xia, X., Zhang, W., Xia, Z., & Jiang, F. (2005). Antidepressant-like effect of icariin and its possible mechanism in mice. Pharmacology, Biochemistry and Behavior,2005(82), 686–694.
13. Pan, Y., Wang, F. M., Qiang, L. Q., Zhang, D. M., & Kong, L. D. (2010). Icariin attenuates chronic mild stress-induced dysregulation of the LHPA stress circuit in rats. Psychoneuroendocrinology,2010(35), 272–283.
14. Zeng, K. W., Fu, H., Liu, G. X., & Wang, X. M. (2010). Icariin attenuates lipopolysaccharide-induced microglial activation and resultant death of neurons by inhibiting TAK1/IKK/NF-kappaB and JNK/p38 MAPK pathways. International Immunopharmacology,2010(10), 668–678.
15. Wu, J., Zhou, J., Chen, X., Fortenbery, N., Eksioglu, E. A., Wei, S., & Dong, J. (2012). Attenuation of LPS-induced inflammation by ICT, a derivate of icariin, via inhibition of the CD14/TLR4 signaling pathway in human monocytes. International Immunopharmacology,2012(12), 74–79.
16. Liu, B., Zhang, H., Xu, C., Yang, G., Tao, J., Huang, J., et al. (2011). Neuroprotective effects of icariin on corticosterone-induced apoptosis in primary cultured rat hippocampal neurons. Brain Research,2011(1375), 59–67.
17. Wang, Q., Hao, J., Pu, J., Zhao, L., Lu, Z., Hu, J., et al. (2011). Icariin induces apoptosis in mouse MLTC-10 Leydig tumor cells through activation of the mitochondrial pathway and down-regulation of the expression of piwil4. International Journal of Oncology,2011(39), 973–980.
18. Yang, J. X., Fichtner, I., Becker, M., Lemm, M., & Wang, X. M. (2009). Anti-proliferative efficacy of icariin on HepG2 hepatoma and its possible mechanism of action. American Journal of Chinese Medicine,2009(37), 1153–1165.
19. Bao, H., & Chen, L. (2011). Icariin reduces mitochondrial oxidative stress injury in diabetic rat hearts. Zhongguo Zhong Yao Za Zhi.,2011(36), 1503–1507.
20. Song, Y. H., Cai, H., Gu, N., Qian, C. F., Cao, S. P., & Zhao, Z. M. (2011). Icariin attenuates cardiac remodelling through down-regulating myocardial apoptosis and matrix metalloproteinase activity in rats with congestive heart failure. Journal of Pharmacy and Pharmacology,2011(63), 541–549.
21. Zhang, Q., Li, H., Wang, S., Liu, M., Feng, Y., & Wang, X. (2013). Icariin protects rat cardiac H9c2 cells from apoptosis by inhibiting endoplasmic reticulum stress. International Journal of Molecular Sciences,2013(14), 17845–17860.
22. Wu, H., Yan, Y., & Backer, J. M. (2007). Regulation of class IA PI3Ks. Biochemical Society Transactions,2007(35), 242–244.
23. Vanhaesebroeck, B., Leevers, S. J., Panayotou, G., & Waterfield, M. D. (1997). Phosphoinositide 3-kinases: A conserved family of signal transducers. Trends in Biochemical Sciences,1997(22), 267–272.
24. Ha, T., Hua, F., Liu, X., Ma, J., McMullen, J. R., Shioi, T., et al. (2008). Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism. Cardiovascular Research,2008(78), 546–553.
25. Chung, B. H., Kim, J. D., Kim, C. K., Kim, J. H., Won, M. H., Lee, H. S., et al. (2008). Icariin stimulates angiogenesis by activating the MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways in human endothelial cells. Biochemical and Biophysical Research Communications,2008(376), 404–408.
26. Xu, C. Q., Liu, B. J., Wu, J. F., Xu, Y. C., Duan, X. H., Cao, Y. X., & Dong, J. C. (2010). Icariin attenuates LPS-induced acute inflammatory responses: Involvement of PI3K/Akt and NF-kappaB signaling pathway. European Journal of Pharmacology,2010(642), 146–153.
27. Ji, Y., Pang, Q. F., Xu, G., Wang, L., Wang, J. K., & Zeng, Y. M. (2008). Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury. European Journal of Pharmacology,2008(587), 1–7.
28. Bar-Or, D., Lau, E., & Winkler, J. V. (2000). A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—A preliminary report. Journal of Emergency Medicine,2000(19), 311–315.
29. Ertl, G., & Frantz, S. (2005). Wound model of myocardial infarction. American Journal of Physiology Heart and Circulatory Physiology,2005(288), H981–H983.
30. Ma, X. L., Kumar, S., Gao, F., Louden, C. S., Lopez, B. L., Christopher, T. A., et al. (1999). Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation,1999(99), 1685–1691.
31. Sedlak, T. W., Oltvai, Z. N., Yang, E., Wang, K., Boise, L. H., Thompson, C. B., & Korsmeyer, S. J. (1995). Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proceedings of National Academy of Sciences of the United States of America,1995(92), 7834–7838.